TY - JOUR
T1 - Designing and evaluating advanced adaptive randomised clinical trials
T2 - a practical guide
AU - Granholm, Anders
AU - Jensen, Aksel Karl Georg
AU - Lange, Theis
AU - Perner, Anders
AU - Møller, Morten Hylander
AU - Kaas-Hansen, Benjamin Skov
N1 - 63 pages (30 without appendices), 5 figures (3 without appendices), 3 tables
PY - 2025
Y1 - 2025
N2 - Background Advanced adaptive randomised clinical trials are increasingly used. Compared to their conventional counterparts, their flexibility may make them more efficient, increase the probability of obtaining conclusive results without larger samples than necessary, and increase the probability that individual participants are allocated to more promising interventions. However, limited guidance is available on designing and evaluating the performance of advanced adaptive trials. Methods We summarise the methodological considerations and provide practical guidance on the entire workflow of planning and evaluating advanced adaptive trials using adaptive stopping, adaptive arm dropping, and response-adaptive randomisation within a Bayesian statistical framework. Results This comprehensive practical guide covers the key methodological decisions for advanced adaptive trials and their specification and evaluation using statistical simulation. These considerations include interventions and common control use; outcome type and generation; analysis timing and outcome-data lag; allocation rules; analysis model; adaptation rules for stopping and arm dropping; clinical scenarios assessed; performance metrics; calibration; sensitivity analyses; and reporting. The considerations are covered in the context of realistic examples, along with simulation code using the adaptr R package. Conclusions This practical guide will help clinical trialists, methodologists, and biostatisticians design and evaluate advanced adaptive trials.
AB - Background Advanced adaptive randomised clinical trials are increasingly used. Compared to their conventional counterparts, their flexibility may make them more efficient, increase the probability of obtaining conclusive results without larger samples than necessary, and increase the probability that individual participants are allocated to more promising interventions. However, limited guidance is available on designing and evaluating the performance of advanced adaptive trials. Methods We summarise the methodological considerations and provide practical guidance on the entire workflow of planning and evaluating advanced adaptive trials using adaptive stopping, adaptive arm dropping, and response-adaptive randomisation within a Bayesian statistical framework. Results This comprehensive practical guide covers the key methodological decisions for advanced adaptive trials and their specification and evaluation using statistical simulation. These considerations include interventions and common control use; outcome type and generation; analysis timing and outcome-data lag; allocation rules; analysis model; adaptation rules for stopping and arm dropping; clinical scenarios assessed; performance metrics; calibration; sensitivity analyses; and reporting. The considerations are covered in the context of realistic examples, along with simulation code using the adaptr R package. Conclusions This practical guide will help clinical trialists, methodologists, and biostatisticians design and evaluate advanced adaptive trials.
KW - stat.ME
UR - https://arxiv.org/abs/2501.08765
M3 - Journal article
SN - 2331-8422
JO - arXiv
JF - arXiv
ER -